Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
283.6 SEK | -0.21% |
|
+2.60% | +6.22% |
06-19 | Sobi Wins EU Approval for Hemophilia A Drug Altuvoct | MT |
06-19 | European Commission Grants Sobi® Marketing Authorisation for Altuvoct? for Treatment of Haemophilia A | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.22% | 9.09B | |
+2.99% | 95.18B | |
-4.34% | 37.55B | |
+75.79% | 28.2B | |
-14.61% | 15.63B | |
-3.46% | 13.63B | |
-12.31% | 11.5B | |
+184.77% | 10.81B | |
-54.13% | 9.23B | |
-13.92% | 7.67B |
- Stock Market
- Equities
- SOBI Stock
- News Swedish Orphan Biovitrum AB
- Transcript : Swedish Orphan Biovitrum AB - Special Call